Company Filing History:
6 out of 46 
5 out of 5 
1 out of 5 
Years Active: 2017-2025
Title: The Innovations of Steven R Fuhrmann
Introduction
Steven R Fuhrmann is a notable inventor based in Germantown, MD (US). He holds a total of 7 patents, showcasing his contributions to the field of biotechnology. His work primarily focuses on the development of isolated polypeptides that have significant applications in neutralizing toxins.
Latest Patents
Among his latest patents is the invention titled "Isolated polypeptide of the toxin A and toxin B proteins and uses thereof." This invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides that comprise the receptor binding domains of toxin A and toxin B, as detailed in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. These isolated polypeptides are designed to neutralize the toxic effects of toxin A and/or toxin B, highlighting their potential therapeutic applications.
Career Highlights
Throughout his career, Steven has worked with prominent companies in the biotechnology sector, including Valneva Austria GmbH and Valneva USA, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions in the field.
Collaborations
Steven has collaborated with notable professionals in his field, including Larry R Ellingsworth and David Flyer. These collaborations have likely enriched his work and expanded the impact of his inventions.
Conclusion
Steven R Fuhrmann's contributions to biotechnology through his patents and collaborations demonstrate his commitment to innovation. His work in developing isolated polypeptides for toxin neutralization is a testament to his expertise and dedication to advancing scientific knowledge.